Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Allan Fettig and Aaron Finley, co-owners of Trumm Drug and recipients of the 2019 Health Mart Pharmacy of the Year Award, discuss how they went about taking ownership of the pharmacy in April 2018.

Daratumumab (Darzalex, Janssen) is indicated for use in combination with lenalidomide and dexamethasone for patients with newly-diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

In a prepared statement, Pharmacy Quality Alliance (PQA) Chief Executive Officer Laura Cranston, RPh, said the organization applauds the initiatives outlined in “Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First.”

Travel health services involves a lot more than vaccinations, said Sheri Stensland, PharmD, in a session at McKesson ideaShare.

Eculizumab (Soliris) is indicated for adult patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive.

The advisory board voted unanimously on Wednesday to recommend HPV vaccines for people through age 26.

Nimesh Jhaveri, President of Health Mart, discusses how local pharmacies can grow their patient base.

Avatrombopag was previously approved by the agency for treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure.

Chris Cella, VP of RxOwnership, on how Trumm Drug’s change in ownership was a good model to follow.

CRSwNP often occurs with severe asthma and requires systemic steroids or nasal surgery, the current standard of care.

Bruce Kneeland, community pharmacy consultant, discusses point-of-care testing as a form of cash-paid services, in an interview with Pharmacy Times.

The drug is earned the designation for reducing the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.

Trumm Drug, a pharmacy serving Alexandria, Minnesota, has been named the Health Mart Pharmacy of the Year by McKesson Pharmaceutical.

Tom Kraus, of ASHP, says pharmacists should play an active role in advocating for policy changes and legislative actions.

The letters request actions to correct violations cited by the agency.

Due to physician shortages, pharmacists represent a new avenue to increase accessibility to antivirals.

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses how the hospital utilizes IV robotics.

Announced by both companies today, the new combined company will consist of franchises across immunology, hematologic oncology, medical aesthetics, neuroscience, women’s health, eye care, and virology.

The approved product is therapeutically equivalent to Genentech’s Tamiflu I Capsules, 30 mg, 45 mg, and 75 mg.

Tera Moore, National Program Manager with the VA Pharmacy Benefits Management Clinical Pharmacy Practice Office, discusses the role that psychiatric pharmacist providers play in their patients' mental health management.

Based on this analysis, a standardized TOC pharmacy education program for COPD was implemented at Rhode Island Hospital in late 2018.

In an effort to combat the opioid epidemic, Walgreens has introduced its recently announced an addition to its drug disposal program in the form of DisposeRx packets.

Why did the doctor lower this patient's gabapentin dose?

Rotavirus is a contagious viral infection causing gastroenteritis that generally affects infants and young children.

The effectiveness and safety of bremelanotide were studied in a pair of 24-week, randomized, double-blind, placebo-controlled trials in 1247 premenopausal women with acquired, generalized HSDD.

This approval expands tezacaftor/ivacaftor’s indication to include patients ages 6 and older with cystic fibrosis who have certain genetic mutations.

Introduced by U.S. Senator Kamala D. Harris (D-CA), the bill requires all insurance plans to cover HIV prevention medications and services without out-of-pocket costs. The bill also facilitates access to PrEP for uninsured individuals.